Best CRT - D Treatment Hospitals Worldwide

University Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 1842, the SAC hospital is located in Basel, Switzerland, and operates 773 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

Millennium Cancer Center provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2004, the hospital is located in Gurgaon, India, and operates 100 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

At Hospital Quironsalud Barcelona, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 1944, this JCI, ISO hospital in Barcelona, Spain has 165 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

At Avcilar Anadolu Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 1998, this JCI hospital in Istanbul, Turkey has 120 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Centro Medico Teknon offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 1994, the JCI hospital is located in Barcelona, Spain and has 211 beds, providing comprehensive care for local and international patients.

CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

Carolina Medical Center provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 1998, the ISO hospital is located in Warsaw, Poland, and operates 60 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

Choosing Centre International Carthage Medical for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2014, the hospital in Monastir, Tunisia has 120 beds and provides specialised cardiac services.

CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.

Max Super Speciality Hospital, Patparganj provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2005, the NABH, NABL, AACI hospital is located in Delhi, India, and operates 400 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

Rutherford Cancer Centre South Wales is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1956, the hospital is situated in Wales, United Kingdom and has 89 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

At The London Clinic, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in , this JCI hospital in London, United Kingdom has 234 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

At Farrer Park Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2016, this hospital in Singapore, Singapore has 220 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Srikara Hospitals, Miyapur is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2013, the NABH hospital is situated in Hyderabad, India and has 200 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

At Tx Hospitals Banjara Hills, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2020, this JCI, NABH hospital in Hyderabad, India has 100 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Ekol offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2000, the ISO hospital is located in Izmir, Turkey and it has adequate bed capacity, providing comprehensive care for local and international patients.

CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

Choosing Woodlands Hospital for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2001, the hospital in Darlington, United Kingdom has 38 beds and provides specialised cardiac services.

CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.